Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	251.86M
Revenue (ttm)	154.95M
Net Income (ttm)	4.00M
Shares Out	10.03M
EPS (ttm)	0.39
PE Ratio	64.44
Forward PE	21.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37
Average Volume	418
Open	25.00
Previous Close	25.10
Day's Range	25.00 - 25.15
52-Week Range	23.20 - 26.50
Beta	0.38
RSI	48.76
Earnings Date	Jul 25, 2025

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 326
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.